Pylum Biosciences
South San Francisco, US · Founded 2016 · Delaware corporation
Pylum Bio is a biotechnology company developing therapeutics, drawing on microbiology, immunology, and molecular genetics research. Its leadership includes founders and directors with backgrounds in pharmaceutical R&D and life sciences.
Founders & leadership
Pylum Biosciences was founded in 2016 by David W. Martin, James L. Knighton, and Jeffery F. Miller.
DW
David W. MartinCo-founder
JL
James L. KnightonCo-founder
JF
Jeffery F. MillerCo-founder
JK
James KnightonNamed on SEC filing
SC
Stephen CreagerNamed on SEC filing
DM
David MartinNamed on SEC filing
KC
Kevin CameronNamed on SEC filing
JM
Jeffrey MillerNamed on SEC filing
MB
Miguel BarbosaNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$990K disclosed across 1 round · 2020
▶$990KraisedMar 2020 · 29 investors · BiotechnologyRule 506(c)
▶$990KraisedMar 2020 · 29 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- James KnightonExecutive Officer, Director
- Stephen CreagerExecutive Officer
- David MartinDirector
- Kevin CameronDirector
- Jeffrey MillerDirector
- Miguel BarbosaDirector
- Offering amount
- $1M
- Amount sold
- $990K
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlapPillar Biosciences9 shared keywordsPillar Biosciences develops kitted next-generation sequencing (NGS) panels and its SLIMamp single-tube library preparation technology for clinical and research laboratories, focused on cancer diagnostics. Its oncoReveal portfolio of RUO and IVD oncology panels covers solid tumors, hematologic cancers, and liquid biopsy, aiming to deliver faster, lower-cost genomic testing for precision medicine.
Lumen8 shared keywordsLumen develops orally-delivered biologic drugs using genetically engineered spirulina algae, which expresses therapeutic proteins such as enzymes, antibodies, and cytokines that are spray-dried into shelf-stable powders and capsules. Its pipeline targets conditions including weight loss, C. difficile, Crohn's disease, ulcerative colitis, and respiratory infections.
Talus Bio8 shared keywordsTalus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts. The company designs AI-driven compounds and uses functional proteomics to enable drug discovery for transcription factors and regulatory proteins implicated in oncology, rare disease, and immune dysfunction.
Mirum Pharmaceuticals8 shared keywordsMirum Pharmaceuticals is a biopharmaceutical company that develops and delivers therapies for people living with rare diseases. It operates in the U.S. and Europe, engaging with healthcare professionals, patients, and payers within applicable regulatory frameworks.
Epirium8 shared keywordsEpirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy. The company's lead compound, EPM-01, is in Phase 1 clinical development for Becker muscular dystrophy.
Precision BioSciences7 shared keywordsPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).
TATUM Bioscience7 shared keywordsTATUM Bioscience develops nanofilament-based immunotherapy for cancer treatment, designed to increase tumor visibility and restore immune function to produce antitumor responses. The company operates in the immuno-oncology field within biotech.
Companies competing with Pylum Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Pylum Biosciences do?
- Pylum Bio is a biotechnology company developing therapeutics, drawing on microbiology, immunology, and molecular genetics research. Its leadership includes founders and directors with backgrounds in pharmaceutical R&D and life sciences.
- Who founded Pylum Biosciences?
- Pylum Biosciences was founded by David W. Martin, James L. Knighton, Jeffery F. Miller in 2016.
- How much funding has Pylum Biosciences raised?
- Pylum Biosciences has disclosed $990K raised across 1 round.
- Where is Pylum Biosciences headquartered?
- Pylum Biosciences is headquartered in South San Francisco, US.